Category: Amlan In the News

Flemming L. Mahs Named President of Amlan International

Posted on | by Chris Underdown

CHICAGO — August 6, 2018 — Amlan International, a Nevada corporation and subsidiary of Oil-Dri Corporation of America (NYSE: ODC), announces the appointment of Flemming L. Mahs as president. Mr. Mahs replaces Ron Cravens, DVM, a veteran animal health professional, who is retiring after 12 years with the company and 35 years in the industry.

Mr. Mahs brings extensive international business leadership experience to Amlan International, a global leader in the development of innovative products that improve intestinal health and productivity in livestock. Mr. Mahs’ cross-functional management experience, multicultural development and growth success is a great fit with the Amlan mission.

Mr. Mahs received his MBA from Washington University, Olin Business School in St. Louis, Missouri and is a Certified Public Accountant. Prior to joining Amlan, he held progressive management positions in general management, finance, operations, business development and marketing at multinational companies in both the animal science and technology industries.

“We are extremely pleased to welcome Flemming to the Oil-Dri family. We look forward to his strategic management contributions as we continue to grow Amlan,” said Dan Jaffee, President and CEO of Oil-Dri. “His appointment reaffirms our commitment to delivering proven, natural feed additives for optimal livestock health and productivity.”

“I’m honored to join this growing team of accomplished animal health professionals,” Mr. Mahs said. “I am excited to deliver the Amlan message and demonstrate how our natural alternatives to antibiotic growth promoters can help producers meet their ROI goals. I look forward to driving the business to even greater levels of success.”

Amlan’s product portfolio includes growth promotion products such as Varium ® for poultry and NeoPrime ™ for post-weaning piglets; bacterial toxin control such as Calibrin ® -Z that adsorbs damaging toxins in the animal’s digestive system; and a full line of functional feed additives that enhance animal production performance.

For more information about Amlan’s portfolio of natural feed additives, visit Amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan to Highlight Advancements in Natural Feed Additives For Supporting Intestinal Health at AMVEC Swine Conference

Posted on | by Chris Underdown

Mérida, Mexico — JULY 10, 2018 — Amlan International, a global leader in developing advanced solutions to enhance intestinal health and productivity in livestock, will partner with its regional distributor, AgroMex, to promote its natural feed additives at the Mexican Association of Veterinary Specialists in Swine Conference (AMVEC). AMVEC is being held July 17–20, 2018, in Mérida, Mexico. Conference attendees can visit Amlan at Booth # 83-86 to learn how to increase the performance of their sows and piglets. Amlan will host “Dia de los Cerdos” themed activities at its booth on July 18 and 19 from 1:30 to 3:30 p.m.

Bacterial-related diseases can cause intestinal damage and block the absorption of essential nutrients in pigs, resulting in higher feed costs and decreased performance. Strengthening the intestinal barrier and priming the immune system needs to be a priority for producers in order to increase their profits. Amlan’s interactive exhibit at AMVEC will feature technical experts who will provide an overview of Amlan’s intestinal health management solutions, including NeoPrime™ and Calibrin®-Z, two unique feed additives from its product portfolio which help bring new life to swine operations.

“Stop by Booth 83–86 to get to know us and learn how our products have been proven to help Mexican producers meet their goals for healthy, productive operations,” says Margarita Santa, Regional Sales Manager, Amlan International.

For more information about Amlan’s portfolio of natural feed additives, visit Amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Dr. Lillehoj to Speak at APPC

Posted on | by Chris Underdown

BANGKOK, THAILAND – March 22, 2018 – Amlan International, a leader in the supply of innovative solutions to improve intestinal health and productivity for livestock, announces that Dr. Hyun Soon Lillehoj, a senior research immunologist at the United States Department of Agriculture (USDA), will present on alternatives to in-feed antibiotics at the Asia Pacific Poultry Conference (APPC) in Bangkok, being held March 25–27, 2018.

Dr. Lillehoj is recognized worldwide as a leading authority on the research and development of antibiotic alternatives for the prevention and treatment of poultry diseases. She is the recipient of numerous awards for excellence in research in poultry diseases and health that span her entire career. She will make her presentation, titled “Immune Modulation of Host Response to Coccidiosis and Necrotic Enteritis to Reduce Antibiotics,” on Tuesday, March 27, 2018, in the Crystal A Room, The Athenee Hotel, Bangkok.

“Restrictions on the use of antibiotic growth promoters remain one of the biggest challenges for poultry producers,” says Ron Cravens, president, Amlan International, a Nevada corporation. “We’re delighted to bring Dr. Lillehoj’s expertise to the APPC and, along with our depth of experience in innovative intestinal health additives, provide a productive dialogue on viable approaches to protecting animals from biotoxic challenges to enhance livestock health and performance.”

For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com. Note to media: For an interview with Dr. Lillehoj, please contact Reagan Culbertson at 312.706.3256 (United States), or reagan.culbertson@amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
press@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois.

Amlan International sells animal health products outside of the United States. Product associated claims do not constitute medical claims and may differ based on government requirements. Product availability may vary by country.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Beyond AGPs: Advancements In Natural Feed Additives Help Drive Progress In Poultry Production

Posted on | by Chris Underdown

HO CHI MINH CITY, Vietnam – March 21, 2018 – Advancements in natural feed additives will help transform the poultry industry by providing a proven and reliable alternative to antibiotic growth promoters (AGPs) for improved performance and reduced mortality, according to Dr. Sim of Amlan International, a global leader in the development of innovative solutions to improve the health and productivity in livestock. Dr. Sim addressed producers, livestock veterinarians and industry leaders last week at ILDEX Vietnam, the biennial International Livestock, Dairy, Meat Processing and Aquaculture Exposition in Ho Chi Minh City.

Dr. Maximillian Sim, DVM, Amlan’s Southeast Asia Commercial and Technical Consultant, was a featured technical speaker at the conference, where he made the well-received presentation, “VariumÔ: Your Solution to Sustainability and Profitability in Antibiotic-Free Poultry Production.”

“Poultry producers worldwide lose $6 billion annually due to disease in their flocks. The reduction and elimination of AGPs in poultry diets has led to increased intestinal health challenges and a higher incidence of diseases such as necrotic enteritis, leading to significant economic losses for producers,” Dr. Sim stated. “A series of studies has shown that Varium provides benefits for poultry producers in the form of increased weight gain, reduced mortality and improved feed conversion – leading to stronger economic performance.”

In 2017, Amlan launched both of its newest growth promotion products in Vietnam, Varium for poultry and NeoPrimeÔ for post-weaning piglets, at an event they hosted for global industry leaders and targeted regional customers.

“Amlan is receiving positive feedback from Varium customers in Vietnam, one of the fastest-growing economies in the world, where changing dietary habits and rising incomes are resulting in dramatic increases in meat consumption,” says Dr. Ron Cravens, MS, DVM, President, Amlan International, a Nevada company. “Our growing portfolio of feed additive solutions is helping global producers meet the increasing demand for meat protein while also enabling them to maximize revenue and profit.”

To meet the demand, producers and nutritionists are looking for viable, drug-free alternatives to support intestinal health and improve performance. Natural, formulated feed additives such as Varium can provide an effective way to enhance performance with or without the inclusion of antibiotics.

Dr. Sim’s presentation at ILDEX focused on Varium research results and the implications for the poultry industry. He has 13 years of experience working in the animal health industry, providing field technical services and market development of nutraceutical products in Asia.

For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
press@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois.

Amlan International sells animal health products outside of the United States. Product associated claims do not constitute medical claims and may differ based on government requirements. Product availability may vary by country.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Receives Patent in China for Intestinal Health Formulation

Posted on | by Chris Underdown

CHICAGO— Amlan International recently received a patent in China for its formulated intestinal health products. The products have three distinct modes of action that work together to strengthen the intestinal environment of livestock.

Patents for the same formula are currently pending in the United States and additional strategic countries. “Science and research are the foundation of our discovery process to naturally improve animal performance by protecting intestinal health,” says Ron Cravens, President, Amlan International, a Nevada corporation. “The issuance of the patent in China is further validation of our development strategy and the value of both our research and products.”

The patent covers two products specifically formulated for their respective species. In poultry, Varium improves feed efficiency, promotes growth and reduces mortality while replacing or enhancing existing antibiotic growth promoters. NeoPrime stimulates a healthy intestinal environment and primes the immune system for improved post-weaning piglet performance. The feed additives are being continuously proven efficacious in the field by outperforming competitive products and enabling producers to maximize both revenue and profit.

“An emerging focus in animal health is promoting the growth of livestock by strengthening the intestinal barrier to resist disease,” Cravens says. “Amlan is at the forefront of developing natural solutions that allow the animal to naturally defend itself by reducing intestinal pathogens and their biotoxins.” In 2013, the company’s global reach expanded with the establishment of a subsidiary in Shenzhen, China. For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Announces Opening of New Laboratory

Posted on | by Chris Underdown

CHICAGO— Amlan International, a global leader in feed additives that improve intestinal health, today announced the opening of its Richard M. Jaffee Laboratory for Applied Microbiology located at the company’s Innovation Center in Vernon Hills, Illinois. The investment includes advanced microbiologists, research instruments and equipment dedicated to accelerating Amlan’s technical expertise and new product development.

The Company also announced the hiring of two Senior Research Microbiologists, Dongping Wang, Ph.D. and Shalaka Shinde, Ph.D. The new teammates are experienced microbiologists with specialized expertise and will help advance the company’s efforts in Life Sciences research.

The Biosafety Level 2 lab enables the examination of materials, such as animal feed, intestinal tissue and feces, and their interaction with bacteria or fungus. Pathogen identification, biotoxin diagnosis and bacterial strain enumeration can now be achieved with the lab’s technical and diagnostic capabilities such as the analyses of DNA and RNA proteins (PCR), antimicrobial assays (MIC & MBC), cellular and morphological analyses (Optical Microscopy) and tissue culturing.

Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated “We are excited that the new lab will allow us to further our understanding of how our products support intestinal health from within the microbiota. Additionally, we aspire to leverage our expertise and new tools to collaborate with our customers by offering diagnostic testing and technical support. I am confident that the new lab will allow us to optimize our existing product offerings and take product development to new heights.”

The lab was named after Richard M. Jaffee, Chairman of Amlan’s parent company, Oil-Dri Corporation of America. His pioneering spirit and vision for Oil-Dri to conduct research in life sciences has been influential in the development of Amlan’s value-added animal health products. In addition to the previously discussed initiatives, the lab will be used by all facets of Oil-Dri’s business and its development is an investment in the future of the company as a whole.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

 

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Dr. Margie Lee (UGA) to Speak at Amlan International’s Global Sales Meeting in Chicago

Posted on | by Chris Underdown

CHICAGO, IL.— Amlan International, a leader in intestinal health in the global animal health and nutrition industry announces that Dr. Margie D. Lee, Professor of Population Health & Diagnostic Laboratory Director, Poultry Diagnostic and Research Center & College of Veterinary Medicine at The University of Georgia, will speak at their Global Sales Meeting on Wednesday, September 13th. Her presentation will focus on bacterial pathogenesis and potential mechanisms of antibiotic alternatives in poultry production.

Dr. Lee’s research is focused on epidemiology of meat and poultry-borne food safety pathogens, microbial pathogenesis, and ecology of poultry intestinal microbiome. Her research has been featured in 77 peer-reviewed publications as well as chapters in the Merck Veterinary Manual and the Laboratory Manual for Isolation.

Dr. Ron Cravens, President of Amlan International, a Nevada corporation, stated, “We are excited to have Dr. Lee address our team. I am confident that her industry experience will provide helpful insight in communicating with our customers.”

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Launches New Educational Website

Posted on | by ideamktg

CHICAGO, IL—Amlan International, known to improve livestock productivity around the world, introduces its new website with interactive elements designed to further educate the industry on the significance of intestinal health and enteric diseases to their bottom-line. This newly redesigned website presents simple access to essential information that offers species specific research and detailed product information. Advanced medical animations allow viewers to engage in the company’s content and offers a distribution map linking to Amlan sales representatives’ contact info.

The new website has improved functionality and is in-line with Amlan’s new strategic vision. Product information is comprehensive and current.

“We are excited to launch our new website and the rich content it will provide our customers, consumers, and media,“ said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation. “This website will focus on our mission of researching and developing products that lead to better intestinal health.”

Amlan International’s new website will be updated regularly with new product data, news releases, and events. Visitors are encouraged to visit Amlan International at Amlan.com and sign up for their newsletter and to receive new product content.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

Source: Global News Wire

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Natural Growth Promoter for Poultry Demonstrates 10:1 ROI, Better than Antibiotics Alone

Posted on | by ideamktg

CHICAGO, IL—A recent study found that Varium™, the natural growth promoter for poultry from Amlan International, performed better than antibiotics alone, delivering significant reductions in mortality, and improvements in feed conversion and intestinal health, for a 10:1 return on investment.

“As the reduction or elimination of antibiotics in broiler production continues to expand worldwide, Varium is proving to be an effective way to enhance the growth-promoting abilities of antibiotics, or, when used in antibiotic-free production, to achieve bird performance equivalent to flocks receiving sub-therapeutic levels of antibiotics,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation.

“We’re very pleased our customers’ broilers receiving Varium, experienced improved villi height and a reduction in crypt depth indicating improved intestinal integrity,” said Cravens. “It’s quite notable that an improved European Efficiency Index (EEI) score was also seen, increasing from 350 to 400 points.”

Compared to the control diet that included antibiotics, feeding Varium decreased mortality by 40%, from 6.93% to 4.18%, with improvements seen throughout the growout period, not just in young birds. Feed conversion improved 15 points, from 1.64 to 1.49, with the majority of the gains seen after day 7 and a greater response seen in female broilers.

Varium is a registered product in a variety of countries, including China and Mexico. For a full list of registered countries and a complete study of the results and more information on Varium, please visit Amlan.com. Varium is sold outside the U.S.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

 

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube